Guggenheim Defined Portfolios, Series 2634 has officially received effectiveness for its registration statement, allowing the company to proceed with its planned offerings. This development is significant as it marks a key step in the company’s ability to engage with investors and expand its portfolio offerings.
The company, Guggenheim Defined Portfolios, Series 2634, is categorized under the investment management sector. It is incorporated in Kansas and is based in Lisle, Illinois. The company operates under the Central Index Key (CIK) number 0002119503, and its fiscal year ends on December 31.
The recent filing indicates that the effectiveness date was established on October 23, 2026. The filing states, "finalEffectivenessDispDate: 2026-10-23," confirming the date when the registration statement became effective.
This update may affect various stakeholders, including investors looking for new opportunities and competitors in the investment management industry. With the effectiveness in place, Guggenheim Defined Portfolios, Series 2634 is now positioned to attract investment and possibly expand its market share.
The filing does not say what happens next, leaving the next steps for the company open to speculation.
Company Details and Contact Information
Guggenheim Defined Portfolios, Series 2634 has an Employer Identification Number (EIN) of 481175174. The company is located at 2300 Cabot Drive, Suite 325, Lisle, Illinois, with a zip code of 60532-3622. For any inquiries, stakeholders can contact the company via phone at 630-577-2243.
Filing Information
The registration statement was filed under the Securities Act of 1933, specifically under SEC file number 333-298516. This filing is categorized as a Form S-6, which is typically used for unit investment trusts.
"The effectiveness of the registration statement allows Guggenheim Defined Portfolios, Series 2634 to offer its investment products to the public, enhancing its ability to raise capital and meet investor demand."
While the filing confirms the effectiveness date and provides essential company information, it does not detail the specific investment products or strategies that will be offered as part of this registration. Additionally, there is no information regarding the anticipated timeline for the offerings or any potential changes in management or strategy following this effectiveness.